Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
244.06
3.55
0.15
0.00
20.10
0.00
10.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
244.06
3.55
0.15
0.00
20.10
0.00
10.00
Raw Material Cost
1.51
1.23
0.81
1.61
0.90
0.60
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
74.03
0.00
0.00
0.00
0.00
5.94
5.09
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Selling and Distribution Expenses
44.84
39.52
34.02
25.91
20.43
12.19
2.75
Other Expenses
5.31
17.36
13.53
8.73
5.51
2.79
1.23
Total Expenditure (Excl Depreciation)
173.44
214.38
170.09
114.79
76.47
46.66
20.12
Operating Profit (PBDIT) excl Other Income
70.6
-210.79999999999998
-169.89999999999998
-114.80000000000001
-56.4
-46.7
-10.1
Other Income
24.33
23.78
16.95
10.11
-0.36
2.62
0.80
Operating Profit (PBDIT)
96.46
-185.82
-152.18
-103.06
-55.83
-43.43
-9.33
Interest
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Exceptional Items
-3.05
0.00
0.00
0.00
0.00
-1.49
-2.56
Gross Profit (PBDT)
242.55
2.32
-0.66
-1.61
19.20
-0.60
0.00
Depreciation
1.51
1.23
0.81
1.61
0.90
0.60
0.44
Profit Before Tax
91.90
-187.05
-152.99
-104.68
-56.73
-45.53
-12.34
Tax
4.88
0.30
0.00
0.00
2.01
-0.17
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
87.01
-187.35
-152.99
-104.68
-58.74
-45.36
-12.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
87.01
-187.35
-152.99
-104.68
-58.74
-45.36
-12.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
87.01
-187.35
-152.99
-104.68
-58.74
-45.36
-12.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
303.13
571.55
332.21
277.42
243.17
261.72
-19.45
Earnings per share (EPS)
2.3
-5.0
-5.2
-4.15
-2.52
-2.93
-0.7
Diluted Earnings per share
2.3
-5.0
-5.2
-4.15
-2.52
-2.93
-0.7
Operating Profit Margin (Excl OI)
28.94%
-5938.96%
-112543.71%
0.0%
-280.46%
0.0%
-105.63%
Gross Profit Margin
38.27%
-5234.48%
-100779.47%
0.0%
-277.79%
0.0%
-118.98%
PAT Margin
35.65%
-5277.55%
-101319.21%
0.0%
-292.26%
0.0%
-123.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 6,874.29% vs 1,650.00% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 146.42% vs -22.48% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 134.40% vs -23.95% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Keros Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
244.06
0.00
244.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
244.06
0.00
244.06
Raw Material Cost
1.51
0.42
1.09
259.52%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
74.03
0.00
74.03
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
44.84
66.39
-21.55
-32.46%
Other Expenses
5.31
23.81
-18.50
-77.70%
Total Expenditure (Excl Depreciation)
173.44
304.86
-131.42
-43.11%
Operating Profit (PBDIT) excl Other Income
70.62
-304.86
375.48
123.16%
Other Income
24.33
68.03
-43.70
-64.24%
Operating Profit (PBDIT)
96.46
-236.41
332.87
140.80%
Interest
0.00
0.00
0.00
Exceptional Items
-3.05
-11.39
8.34
73.22%
Gross Profit (PBDT)
242.55
-0.42
242.97
57,850.00%
Depreciation
1.51
0.42
1.09
259.52%
Profit Before Tax
91.90
-248.23
340.13
137.02%
Tax
4.88
0.00
4.88
Provisions and contingencies
0
0
0.00
Profit After Tax
87.01
-248.23
335.24
135.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
87.01
-248.23
335.24
135.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
87.01
-248.23
335.24
135.05%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
303.13
458.29
-155.16
-33.86%
Earnings per share (EPS)
2.30
-2.50
4.80
192.00%
Diluted Earnings per share
2.30
-2.50
4.80
192.00%
Operating Profit Margin (Excl OI)
28.94%
0.00%
0.00
28.94%
Gross Profit Margin
38.27%
0.00%
0.00
38.27%
PAT Margin
35.65%
0.00%
0.00
35.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 24.41 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 6,874.29% vs 1,650.00% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 8.70 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 146.42% vs -22.48% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.21 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 134.40% vs -23.95% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.94%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
